Andrew Guggenhime, President and CFO: Vaxcyte PCVX Sell · Filed 25/02/19

Trade details

Type: Insider sale
Amount: $153,766.44
Shares · price: 1,818 sh · $84.58 a share
Held after: 109,491 sh
Stock: Vaxcyte PCVX
Person: Andrew GuggenhimePresident and CFO
Trade date: 25/02/18
Filed: 25/02/19
Days to filing: 1 days

Sold 1.6% of holdings

Share of holding sold: 1.6%

Vaxcyte trades, last 26 weeks

What else happened in Vaxcyte around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Andrew Guggenhime's recent trades

Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$539.9K
10,000 sh
$539.9K
Filed 08/03
Traded 08/03
Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$577.6K
10,000 sh
$577.6K
Filed 07/06
Traded 07/06
Andrew GuggenhimePresident and CFO
Sell10b5-1 planVaxcyte
Sell10b5-1 plan
Vaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
Andrew GuggenhimePresident and CFO
Sell10b5-1 planVaxcyte
Sell10b5-1 plan
Vaxcyte
PCVX
$517.1K
6,182 sh
$517.1K
Filed 25/02/19
Traded 25/02/18